iRadimed (NASDAQ:IRMD) reported its Q1 earnings results on Friday, April 29, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
iRadimed beat estimated earnings by 10.0%, reporting an EPS of $0.22 versus an estimate of $0.2.
Revenue was up $3.09 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 23.66% increase in the share price the next day.
Here's a look at iRadimed's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.21 | 0.17 | 0.09 | 0.10 |
| EPS Actual | 0.33 | 0.23 | 0.14 | 0.13 |
| Revenue Estimate | 11.63M | 10.40M | 8.46M | 8.56M |
| Revenue Actual | 11.87M | 10.91M | 9.81M | 9.22M |
To track all earnings releases for iRadimed visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
